Organogenesis Holdings Inc. (ORGO) Financial Statements (2023 and Earlier)

Company Profile

Business Address 85 DAN ROAD
CANTON, MA 02021
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments113,92984,39460,17421,2911261,040
Cash and cash equivalents113,92984,39460,17421,2911261,040
Restricted cash and investments599412196114  
Receivables82,46056,80439,35934,077  
Inventory, net of allowances, customer advances and progress billings25,02227,79922,91813,321  
Inventory25,02227,79922,91813,321  
Prepaid expense4,9694,9352,9532,328169396
Total current assets:226,979174,344125,60071,1312941,436
Noncurrent Assets
Operating lease, right-of-use asset49,144  
Property, plant and equipment79,16060,06847,18439,623  
Long-term investments and receivables  556477  
Due from related parties  556477  
Intangible assets, net (including goodwill)54,44559,39446,33651,630  
Goodwill28,77228,77225,53925,539  
Intangible assets, net (excluding goodwill)25,67330,62220,79726,091  
Restricted cash and investments    312,498310,000
Deferred income tax assets31,99418 
Other noncurrent assets1,537670884579  
Other undisclosed noncurrent assets  127238  
Total noncurrent assets:216,280120,15095,08792,547312,498310,000
TOTAL ASSETS:443,259294,494220,687163,678312,792311,436
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities65,92847,35451,83744,5803,82951
Accounts payable29,33923,38128,38719,165  
Accrued liabilities36,58923,97323,45025,4153,82951
Debt2,85616,666 10,046  
Restructuring reserve3,168618    
Due to related parties    100 
Business combination, contingent consideration, liability  5,0005,000  
Other undisclosed current liabilities10,0533,5793,0576,762 428
Total current liabilities:82,00568,21759,89466,3883,929478
Noncurrent Liabilities
Long-term debt and lease obligation117,66253,04449,63449,216  
Long-term debt, excluding current maturities70,76953,04449,63439,062  
Capital lease obligations10,154  
Operating lease, liability46,893  
Liabilities, other than long-term debt1,55711,9567,6611,033  
Deferred rent credit  1,012130
Other liabilities1,5577,9716,649903  
Business combination, contingent consideration, liability 3,985    
Other undisclosed noncurrent liabilities 15,19347,915 10,85010,850
Total noncurrent liabilities:119,21980,193105,21050,24910,85010,850
Total liabilities:201,224148,410165,104116,63714,77911,328
Temporary equity, carrying amount    293,014295,108
Stockholders' equity
Stockholders' equity attributable to parent, including:242,035146,08455,58347,0415,0005,000
Common stock1313109  
Additional paid in capital302,155299,129226,580177,2727,3275,233
Accumulated deficit(60,133)(153,058)(171,007)(130,240)(2,328)(234)
Other undisclosed stockholders' equity attributable to parent    11
Total stockholders' equity:242,035146,08455,58347,0415,0005,000
TOTAL LIABILITIES AND EQUITY:443,259294,494220,687163,678312,792311,436

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues468,059338,298260,981193,449  
Cost of revenue(114,199)(87,319)(75,948)(68,808)  
Gross profit:353,860250,979185,033124,641  
Operating expenses(280,942)(223,564)(214,492)(176,197)(4,592)(209)
Operating income (loss):72,91827,415(29,459)(51,556)(4,592)(209)
Nonoperating income (expense)(9,132)(8,936)(10,845)(13,191)2,498 
Investment income, nonoperating   642,498 
Interest and debt expense(1,883)(11,279)(1,862)(2,095)  
Income (loss) from continuing operations before equity method investments, income taxes:61,9037,200(42,166)(66,842)(2,094)(209)
Other undisclosed income from continuing operations before income taxes1,88311,2791,8622,095  
Income (loss) from continuing operations before income taxes:63,78618,479(40,304)(64,747)(2,094)(209)
Income tax expense (benefit)31,116(530)(150)(84)  
Net income (loss) attributable to parent:94,90217,949(40,454)(64,831)(2,094)(209)
Other undisclosed net loss available to common stockholders, basic  (645) (2,342) 
Net income (loss) available to common stockholders, diluted:94,90217,949(41,099)(64,831)(4,436)(209)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):94,90217,949(40,454)(64,831)(2,094)(209)
Comprehensive income (loss), net of tax, attributable to parent:94,90217,949(40,454)(64,831)(2,094)(209)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: